• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

92
32
32
29
25

COUNTRY

27
11
9
7
1

CATEGORIES

  • 79
  • 64
  • 45
  • 30
  • 28
  • 22
  • 16
  • 12
  • 10
  • 10
  • 8
  • 7
  • 6
  • 6
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

132
173
222
284

PUBLISHED

14
20
48
284

PRODUCT TYPE

195
65
21
2
1

Search "New Concepts in Cancer Therapeutics" returned 284 results.

PRODUCT TITLE
Drug Delivery in Cancer - Technologies, Markets and Companies Drug Delivery in Cancer - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Cancer - Technologies, Markets and Companies

Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery...

December 2014
FROM
Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2012 Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2012 - Product Thumbnail Image

Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2012

Cancer Therapeutics CRC Pty Ltd – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2012” provides...

October 2012
FROM
Personalized Medicine - Scientific and Commercial Aspects Personalized Medicine - Scientific and Commercial Aspects - Product Thumbnail Image

Personalized Medicine - Scientific and Commercial Aspects

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her...

December 2014
FROM

Global Prostate Cancer Therapeutics Market (2010 – 2020) (Opportunity Analysis, Pipeline Assessment & Market Forecast)

Prostate cancer is the most frequently diagnosed cancer in men In terms of loss of life from any disease, prostate cancer ranks eleventh; and it ranks sixth in terms of cancer-related mortality in men...

November 2011
FROM
RNAi - Technologies, Markets and Companies RNAi - Technologies, Markets and Companies - Product Thumbnail Image

RNAi - Technologies, Markets and Companies

RNA interference (RNAi) or gene silencing involves the use of double stranded RNA (dsRNA). Once inside the cell, this material is processed into short 21-23 nucleotide RNAs termed siRNAs that are used...

December 2014
FROM
Nanobiotechnology Applications, Markets and Companies Nanobiotechnology Applications, Markets and Companies - Product Thumbnail Image

Nanobiotechnology Applications, Markets and Companies

Nanotechnology is the creation and utilization of materials, devices, and systems through the control of matter on the nanometer-length scale (a nanometer is one billionth of a meter. Nanobiotechnology,...

December 2014
FROM
The Future of RNAi Therapeutics: Drug Pipelines and Prospects The Future of RNAi Therapeutics: Drug Pipelines and Prospects - Product Thumbnail Image

The Future of RNAi Therapeutics: Drug Pipelines and Prospects

"The total RNAi therapy market is estimated to value $580m by 2012 This forecast is based upon current treatments, levels of market satisfaction and five new Phase II/III RNAi agents profiled in this...

September 2008
FROM

Cancer Stem Cells. Identification and Targets

Because the concept and discoveries of cancer stem cells are relatively new, scientists and researchers need an introduction to this dynamic area. Cancer Stem Cells presents a consolidated account of...

November 2008

Cancer Immunotherapy. Edition No. 2

There has been major growth in understanding immune suppression mechanisms and its relationship to cancer progression and therapy. This book highlights emerging new principles of immune suppression...

July 2013
Nitric Oxide - Therapeutics, Markets and Companies Nitric Oxide - Therapeutics, Markets and Companies - Product Thumbnail Image

Nitric Oxide - Therapeutics, Markets and Companies

This report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs. Major segments of the market for nitric oxide-based...

December 2014
FROM
Gene Therapy - Global Strategic Business Report Gene Therapy - Global Strategic Business Report - Product Thumbnail Image

Gene Therapy - Global Strategic Business Report

This report analyzes the Global market for Gene Therapy in US$ Million Annual estimates and forecasts are provided for the period 2009 through 2017 The report profiles 98 companies including many key...

February 2012
FROM
Liver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy And Immunosuppressants) - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018 Liver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy And Immunosuppressants) - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018 - Product Thumbnail Image

Liver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy And Immunosuppressants) - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018

This report covers the performance of the various drugs class segment used in liver disease therapeutics in terms of their revenue The global market for liver diseases therapeutics is classified into...

January 2013
FROM

Gene Therapy of Cancer. Edition No. 3

Gene therapy as a treatment for cancer is at a critical point in its evolution. Exciting new developments in gene targeting and vector technology, coupled with results from the first generation of preclinical...

October 2013
Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities - Product Thumbnail Image

Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities

This cutting edge & insightful report can be used to interpret & assess the potential of RNAi-based medicines It provides opinions & market projections to: - assess the commercial potential of RNAi-based...

July 2009
Pain Therapeutics - Drugs, Markets and Companies Pain Therapeutics - Drugs, Markets and Companies - Product Thumbnail Image

Pain Therapeutics - Drugs, Markets and Companies

This report describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain. Major segments of the pain market are arthritis, neuropathic...

December 2014
FROM
The Molecular Biology of Cancer. A Bridge from Bench to Bedside. 2nd Edition The Molecular Biology of Cancer. A Bridge from Bench to Bedside. 2nd Edition - Product Thumbnail Image

The Molecular Biology of Cancer. A Bridge from Bench to Bedside. 2nd Edition

The Molecular Biology of Cancer, Stella Pelengaris & Michael Khan  This capturing, comprehensive text, extensively revised and updated for its second edition, provides a detailed overview of the...

April 2013

The Molecular Biology of Cancer. A Bridge from Bench to Bedside. 2nd Edition

The Molecular Biology of Cancer, Stella Pelengaris & Michael Khan  This capturing, comprehensive text, extensively revised and updated for its second edition, provides a detailed overview of the...

April 2013
FROM
Personalized Medicine: Companies, Trends and World Market Personalized Medicine: Companies, Trends and World Market - Product Thumbnail Image

Personalized Medicine: Companies, Trends and World Market

This broad, high-level report analyzes the expanding Personalized Medicine market This world market includes important core medical product areas that will continue to have a powerful impact on current...

April 2012
FROM
Tissue Engineering: The Combination of Cells & Engineering - A Global Market Overview Tissue Engineering: The Combination of Cells & Engineering - A Global Market Overview - Product Thumbnail Image

Tissue Engineering: The Combination of Cells & Engineering - A Global Market Overview

Advancements of novel therapies in the fields of tissue engineering and regenerative medicine have opened up new avenues for addressing a range of major diseases such as cancer; skin; cardiovascular...

February 2012
FROM

Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards

Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards Summary GBI Research’s new report, “Gene Therapy Market to...

June 2012
FROM
Loading Indicator

Our Clients

Our clients' logos